• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前 18F-FDG SUVmax>6.3 或原发灶大小>2.3cm 预测外周 cT1 期非小细胞肺癌淋巴结转移,阴性预测值较高。

Preoperative 18F-FDG SUVmax >6.3 or Size >2.3 cm of primary lesions predict lymph nodes metastasis with higher negative predictive value in peripheral cT1 non-small-cell lung cancer.

机构信息

Department of Nuclear Medicine, The Third Affiliated Hospital of Soochow University, Changzhou.

Department of Radiology, Xuzhou Cancer Hospital, Xuzhou.

出版信息

Nucl Med Commun. 2021 Dec 1;42(12):1328-1335. doi: 10.1097/MNM.0000000000001462.

DOI:10.1097/MNM.0000000000001462
PMID:34284441
Abstract

BACKGROUND

Sublobar resection is suitable for peripheral cT1N0M0 non-small-cell lung cancer (NSCLC). The traditional PET-CT criterion (lymph node size ≥1.0 cm or SUVmax ≥2.5) for predicting lymph nodes metastasis (LNM) has unsatisfactory performance.

OBJECTIVE

We explore the clinical role of preoperative SUVmax and the size of the primary lesions for predicting peripheral cT1 NSCLC LNM.

METHODS

We retrospectively analyzed 174 peripheral cT1 NSCLC patients underwent preoperative 18F-FDG PET-CT and divided into the LNM and non-LNM group by pathology. We compared the differences of primary lesions' baseline characteristics between the two groups. The risk factors of LNM were determined by univariate and multivariate analysis, and we assessed the diagnostic efficacy with the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, positive predictive value and negative predictive value (NPV).

RESULTS

Of the enrolled cases, the incidence of LNM was 24.7%. The preoperative SUVmax >6.3 or size >2.3 cm of the primary lesions were independent risk factors of peripheral cT1 NSCLC LNM (ORs, 95% CIs were 6.18 (2.40-15.92) and 3.03 (1.35-6.81). The sensitivity, NPV of SUVmax >6.3 or size >2.3 cm of the primary lesions were higher than the traditional PET-CT criterion for predicting LNM (100.0 vs. 86.0%, 100.0 vs. 89.7%). A Hosmer-Lemeshow test showed a goodness-of-fit (P = 0.479).

CONCLUSIONS

The excellent sensitivity and NPV of preoperative of the SUVmax >6.3 or size >2.3 cm of the primary lesions based on 18F-FDG PET-CT might identify the patients at low-risk LNM in peripheral cT1 NSCLC.

摘要

背景

亚肺叶切除术适用于外周型 T1N0M0 期非小细胞肺癌(NSCLC)。预测淋巴结转移(LNM)的传统 PET-CT 标准(淋巴结大小≥1.0cm 或 SUVmax≥2.5)表现不佳。

目的

我们旨在探讨术前 SUVmax 和原发肿瘤大小对预测外周型 T1 NSCLC LNM 的临床作用。

方法

我们回顾性分析了 174 例接受术前 18F-FDG PET-CT 检查的外周型 T1 NSCLC 患者,根据病理结果分为 LNM 组和非 LNM 组。我们比较了两组患者原发肿瘤基线特征的差异。采用单因素和多因素分析确定 LNM 的危险因素,并通过受试者工作特征曲线(ROC)下面积(AUC)、敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)评估诊断效能。

结果

本研究中 LNM 的发生率为 24.7%。术前 SUVmax>6.3 或原发肿瘤大小>2.3cm 是外周型 T1 NSCLC LNM 的独立危险因素(OR 值及其 95%CI 分别为 6.18(2.40-15.92)和 3.03(1.35-6.81))。SUVmax>6.3 或原发肿瘤大小>2.3cm 的敏感性和 NPV 均高于传统 PET-CT 标准预测 LNM(100.0%比 86.0%,100.0%比 89.7%)。Hosmer-Lemeshow 检验显示拟合优度良好(P=0.479)。

结论

基于 18F-FDG PET-CT 的术前 SUVmax>6.3 或原发肿瘤大小>2.3cm 具有良好的敏感性和 NPV,有助于识别外周型 T1 NSCLC 中 LNM 低风险患者。

相似文献

1
Preoperative 18F-FDG SUVmax >6.3 or Size >2.3 cm of primary lesions predict lymph nodes metastasis with higher negative predictive value in peripheral cT1 non-small-cell lung cancer.术前 18F-FDG SUVmax>6.3 或原发灶大小>2.3cm 预测外周 cT1 期非小细胞肺癌淋巴结转移,阴性预测值较高。
Nucl Med Commun. 2021 Dec 1;42(12):1328-1335. doi: 10.1097/MNM.0000000000001462.
2
The value of dual time-point fluorine-18 fluorodeoxyglucose PET/computed tomography imaging in predicting lymph node metastasis in non-small cell lung cancer patients.双时相氟-18 氟代脱氧葡萄糖 PET/计算机断层扫描成像在预测非小细胞肺癌患者淋巴结转移中的价值。
Nucl Med Commun. 2024 Sep 1;45(9):812-817. doi: 10.1097/MNM.0000000000001866. Epub 2024 May 27.
3
Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non-small cell lung cancer patients.氟-18 氟代脱氧葡萄糖正电子发射断层扫描计算机断层扫描肿瘤与肝脏标准摄取比值可有效预测非小细胞肺癌患者隐匿性淋巴结转移。
Nucl Med Commun. 2020 May;41(5):459-468. doi: 10.1097/MNM.0000000000001173.
4
The value on SUV-derived parameters assessed on F-FDG PET/CT for predicting mediastinal lymph node metastasis in non-small cell lung cancer.基于 F-FDG PET/CT 的 SUV 衍生参数在预测非小细胞肺癌纵隔淋巴结转移中的价值。
BMC Med Imaging. 2023 Apr 5;23(1):49. doi: 10.1186/s12880-023-01004-7.
5
An Investigation of the Relationship Between F-FDG PET/CT Parameters of Primary Tumors and Lymph Node Metastasis in Resectable Non-small Cell Lung Cancer.可切除非小细胞肺癌中原发性肿瘤的F-FDG PET/CT参数与淋巴结转移关系的研究
Curr Radiopharm. 2024;17(1):111-116. doi: 10.2174/1874471016666230829100703.
6
Developing a primary tumor and lymph node 18F-FDG PET/CT-clinical (TLPC) model to predict lymph node metastasis of resectable T2-4 NSCLC.建立原发肿瘤和淋巴结 18F-FDG PET/CT-临床(TLPC)模型预测可切除 T2-4 NSCLC 的淋巴结转移。
J Cancer Res Clin Oncol. 2023 Jan;149(1):247-261. doi: 10.1007/s00432-022-04545-6. Epub 2022 Dec 24.
7
Utility of Volumetric Metabolic Parameters on Preoperative FDG PET/CT for Predicting Tumor Lymphovascular Invasion in Non-Small Cell Lung Cancer.术前 FDG PET/CT 容积代谢参数预测非小细胞肺癌肿瘤淋巴管血管侵犯的价值。
AJR Am J Roentgenol. 2021 Dec;217(6):1433-1443. doi: 10.2214/AJR.21.25814. Epub 2021 May 12.
8
Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.基于 FDG PET/CT 的代谢参数对 cN2 期非小细胞肺癌患者淋巴结转移的诊断价值。
BMC Cancer. 2021 Sep 2;21(1):983. doi: 10.1186/s12885-021-08688-6.
9
Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.通过氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描综合分期的临床I期非小细胞肺癌患者隐匿性淋巴结转移的预测危险因素
World J Surg. 2016 Dec;40(12):2976-2983. doi: 10.1007/s00268-016-3652-5.
10
The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.氟脱氧葡萄糖正电子发射断层扫描原发性肿瘤的最大标准化摄取值是临床 N0 非小细胞肺癌病理性淋巴结受累的良好预测指标。
Eur J Cardiothorac Surg. 2013 Jul;44(1):83-7. doi: 10.1093/ejcts/ezs604. Epub 2012 Dec 11.